Pharmaceuticals - , ,
The BioPharm industry spends $75 billion a year to develop and provide new drugs and therapies. Shockingly, many in the industry don't realize 60-75% of their pipelines depends on medical imaging for approval or that outdated technologies are hindering their success. ValiCloud has developed and delivered ways to dramatically shorten the time to market with reduced errors and costs to overcome those threats to pipeline success.ValiCloud effectively removes all barriers between BioPharma decision makers and their clinical image data. Making clinical imaging real-time and actionable for analysis and decisions instead of delayed for months. The ValiCloud solution provides dramatic increases in BioPharma returns on billions of dollars in R&D investment.